The U.S. Drug Enforcement Agency (“DEA”) may issue a decision as soon as this summer regarding the potential downgrading of cannabis to allow for its medical use.
In response to a letter from seven U.S. Senators in December, 2015, the U.S. Drug Enforcement Agency issued a 26-page response in April, 2016, that many believe indicates